NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
4.845
-0.235 (-4.63%)
At close: Sep 29, 2026, 4:00 PM EDT
4.845
0.00 (0.00%)
After-hours: Sep 29, 2026, 4:10 PM EDT
NextCure Employees
NextCure had 40 employees as of December 31, 2025. The number of employees decreased by 3 or -6.98% compared to the previous year.
Employees
40
Change (1Y)
-3
Growth (1Y)
-6.98%
Revenue / Employee
n/a
Profits / Employee
-$1,068,700
Market Cap
22.18M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 40 | -3 | -6.98% |
| Dec 31, 2024 | 43 | -39 | -47.56% |
| Dec 31, 2023 | 82 | -17 | -17.17% |
| Dec 31, 2022 | 99 | 12 | 13.79% |
| Dec 31, 2021 | 87 | -3 | -3.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| TScan Therapeutics | 138 |
| Evaxion | 46 |
| Jasper Therapeutics | 22 |
| LeonaBio | 19 |
| Psyence Biomedical | 12 |
| Cocrystal Pharma | 10 |
| Quoin Pharmaceuticals | 6 |
| Akari Therapeutics, | 6 |
NXTC News
- 7 weeks ago - Avere Therapeutics Announces $500 Million Private Placement to Support Development of Once-Weekly Oral IL-23 Therapy AVR-001 - PRNewsWire
- 7 weeks ago - NextCure reports Q2 EPS ($2.80), consensus ($1.92) - TheFly
- 7 weeks ago - NextCure Quarterly report: Q2 2026 - Filings
- 7 weeks ago - NextCure Earnings release: Q2 2026 - Filings
- 7 weeks ago - NextCure Slides: Corporate presentation - Filings
- 2 months ago - NextCure trading resumes - TheFly
- 2 months ago - NextCure trading halted, volatility trading pause - TheFly
- 2 months ago - Why Is Penny Stock NextCure (NXTC) Up Today? - TipRanks